OPKO HEALTH INC. - COMMON STOCK

OPKO Health Announces Closing of Private Offering of $230 Million Convertible Senior Notes Due 2029 including Full Exercise of Initial Purchaser’s Option to Purchase Additional Notes

09 1 2024 16:05:28 提供 Nasdaq GlobeNewswire

OPKO Health to Present at the 42nd Annual J.P. Morgan Healthcare Conference

08 1 2024 08:00:00 提供 Nasdaq GlobeNewswire

OPKO Health Announces Pricing of Private Offering of $200 Million Convertible Senior Notes Due 2029

04 1 2024 23:31:25 提供 Nasdaq GlobeNewswire

OPKO Health Announces Private Offering of Convertible Senior Notes Due 2029

03 1 2024 17:05:39 提供 Nasdaq GlobeNewswire

OPKO Health Reports Third Quarter 2023 Business Highlights and Financial Results

06 11 2023 16:05:01 提供 Nasdaq GlobeNewswire

New Clinical Data on OPKO Health’s RAYALDEE® (ER Calcifediol) Presented at Kidney Week 2023

02 11 2023 10:00:00 提供 Nasdaq GlobeNewswire

OPKO Health to Report Third Quarter 2023 Financial Results on November 6, 2023

31 10 2023 08:00:01 提供 Nasdaq GlobeNewswire

OPKO Health to Present New Clinical Data on Rayaldee (ER Calcifediol) at Kidney Week 2023

25 10 2023 16:25:11 提供 Nasdaq GlobeNewswire

ModeX Therapeutics Secures BARDA Contract to Develop Novel Multispecific Antibodies Against Viral Infectious Disease Threats

28 9 2023 16:08:06 提供 Nasdaq GlobeNewswire

OPKO Health Reports Second Quarter 2023 Business Highlights and Financial Results

03 8 2023 16:05:01 提供 Nasdaq GlobeNewswire

OPKO Health to Report Second Quarter 2023 Financial Results on August 3, 2023

25 7 2023 16:05:00 提供 Nasdaq GlobeNewswire

OPKO Health Reports First Quarter 2023 Business Highlights and Financial Results

03 5 2023 16:05:01 提供 Nasdaq GlobeNewswire

OPKO Health to Report First Quarter 2023 Financial Results on May 3, 2023

25 4 2023 16:05:00 提供 Nasdaq GlobeNewswire

OPKO Health to Hold Virtual R&D Day on March 20, 2023

09 3 2023 08:00:01 提供 Nasdaq GlobeNewswire

OPKO Health’s ModeX Therapeutics Enters into Exclusive Worldwide License and Collaboration Agreement with Merck to Develop Epstein-Barr Virus Vaccine Candidate

08 3 2023 08:00:00 提供 Nasdaq GlobeNewswire

OPKO Health Reports Fourth Quarter 2022 Business Highlights and Financial Results

23 2 2023 16:05:01 提供 Nasdaq GlobeNewswire

OPKO Health to Report Fourth Quarter 2022 Financial Results on February 23, 2023

16 2 2023 11:41:10 提供 Nasdaq GlobeNewswire

OPKO Health to Present at the 41st Annual J.P. Morgan Healthcare Conference

03 1 2023 08:00:01 提供 Nasdaq GlobeNewswire

OPKO Health Reports Third Quarter 2022 Business Highlights and Financial Results

08 11 2022 16:05:02 提供 Nasdaq GlobeNewswire

OPKO Health to Report Third Quarter 2022 Financial Results on November 8, 2022

01 11 2022 08:00:01 提供 Nasdaq GlobeNewswire